期刊文献+

垂体瘤患者术后垂体功能减退危险因素分析研究 被引量:7

Analysis of Risk Factors for Postsurgicalhy Hypopituitarism in Pituitary Adenoma Patients
下载PDF
导出
摘要 目的探讨垂体瘤患者术后垂体功能减退的危险因素。方法回顾性分析2005—2015年在济宁医学院附属医院行外科手术的439例垂体瘤患者的临床资料,包括性别、年龄、肿瘤直径、肿瘤分型、本次是否复发、侵袭性、垂体卒中、手术方式、肿瘤是否全切、术前垂体功能减退、肿瘤复发等,分析术后垂体功能减退发生的影响因素。结果 439例垂体瘤患者中,微腺瘤17例,大腺瘤356例,巨腺瘤66例。阈值效应分析结果显示,肿瘤直径拐点为22 mm。多因素Logistic回归分析结果显示,肿瘤直径>22 mm[OR=1.23,95%CI(1.15,1.31)]、术前垂体功能减退[OR=3.91,95%CI(1.64,9.09)]是影响术后垂体功能减退的因素(P<0.001)。结论肿瘤直径和术前垂体功能减退是术后垂体功能减退的独立危险因素。 Objective To investigate the risk factors for postsurgical hypopituitarism in patients with pituitary adenomas.Methods We retrospectively reviewed the clinical records of 439 pituitary adenoma patients undergoing surgical treatment in the Affiliated Hospital of Jining Medical University from 2005 to 2015.The review included gender,age,tumor diameter,tumor classification,recurrence or not,tumor invasion,pituitary apoplexy,surgical approaches,total tumor resection or not,presurgical hypopituitarism,and tumor recurrence.The risk factors for postsurgical hypopituitarism were analyzed.Results The 439 pituitary adenoma patients included 17 cases of microadenoma cases,356 of macroadenoma and 66 of giant adenoma.Threshold effect analysis showed that the threshold value of tumor diameter was 22 mm.Multivariate Logistic regression analysis revealed that tumor diameter>22 mm〔OR=1.23,95%CI(1.15,1.31)〕,and development of presurgical hypopituitarism〔OR=3.91,95%CI(1.64,9.09)〕were risk factors for postsurgical hypopituitarism(P<0.001).Conclusion Tumor diameter and presurgical hypopituitarism are independent risk factors for postsurgical hypopituitarism.
作者 陈汉文 孙冰 孙海玲 张丽 徐璐 CHEN Han-wen;SUN Bing;SUN Hai-ling;ZHANG Li;XU Lu(Affiliated Hospital of Jining Medical College,Jining 272000,China;Jining Medical College,Jining 272000,China)
出处 《中国全科医学》 CAS 北大核心 2018年第11期1296-1299,共4页 Chinese General Practice
基金 山东省2015年度中医药科技发展计划项目(2015-243)
关键词 垂体肿瘤 垂体功能减退 危险因素 Pituitary neoplasms Hypopituitarism Risk factors
  • 相关文献

参考文献3

二级参考文献44

  • 1王晓明,何岚,高烨.原发性肾上腺皮质功能减退症20例临床分析[J].中国综合临床,2005,21(3):228-230. 被引量:16
  • 2陈来照,马景鑑,郑安潮,范益民.128例垂体腺瘤回顾性分析[J].山西医科大学学报,2005,36(4):486-489. 被引量:4
  • 3Scheithauer BW,Horvath E,Kovacs K,et al.Plurihormonal pituitary adenomas.Semin Diagn Pathol,1986,3:69-82.
  • 4St-Jean E,Blain F,Comtois R.High prolactin levels may be missed by immunoradiometric assay in patients with macroprolactinomas.Clin Endocrinol(Oxf),1996,44:305-309.
  • 5Abrahamson MJ,Snyder PJ.Causes of hyperprolactinemia.Up to Date,2001,9:1-6.
  • 6Arafah BM,Nasrallah MP.Pituitary tumors:pathophysiology,clinical manifesttations and management.Endocr Relat Cancer,2001,8:287-305.
  • 7Paja M,Lucas T,Garcia Uria J,et al.Hypothalamic-pituitary dysfunction in patients with craniopharyngioma.Clin Endocrinol (Oxf),1995,42:467-473.
  • 8Melmed S.The Pituitary.England,Blackwell Publishers,2002.
  • 9Yousem DM,Arrington JA,Zinreich SJ,et al.Pituitary adenoma:possible role of bromocriptine in intratumoral hemorrhage.Radiology,1989,170:239-243.
  • 10Lundin P,Nyman R,Burman P,et al.MRI of pituitary macroadenomas with reference to hormonal activity.Neuroradiology,1992,(34):43-51.

共引文献44

同被引文献80

引证文献7

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部